Predicting Reduction of Cerebrospinal Fluid β-Amyloid 42 in Cognitively Healthy Controls

JAMA Neurology
Niklas MattssonAlzheimer’s Disease Neuroimaging Initiative

Abstract

Alzheimer disease has a long preclinical stage characterized by β-amyloid (Aβ) accumulation without symptoms. Several trials focus on this stage and use biomarkers to include Aβ-positive participants, but an even earlier prevention of Aβ accumulation may be an effective treatment strategy. To determine whether people who appear to be Aβ negative but are at high risk for Aβ positivity within the near future can be identified. Longitudinal biomarker cohort study involving 35 cognitively healthy individuals who underwent cerebrospinal fluid (CSF) sampling for up to 3 years during the study (October 24, 2005, to September 1, 2014). All participants had normal CSF Aβ42 levels at baseline. Predictors of future Aβ positivity (levels of CSF Aβ42 declining below a previously validated cutoff level of 192 ng/L) tested by random forest models. Tested predictors included levels of protein in the CSF, hippocampal volume, genetics, demographics, and cognitive scores. The CSF Aβ42 levels declined in 11 participants, and the CSF became Aβ positive. The baseline CSF Aβ42 level was a strong predictor of future positivity (accuracy, 79% [95% CI, 70%-87%]). Ten of 11 decliners had baseline CSF Aβ42 levels in the lower tertile of the reference rang...Continue Reading

Citations

Jan 23, 2016·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Valentina BertiAlberto Pupi
Mar 5, 2016·Brain : a Journal of Neurology·Sebastian PalmqvistUNKNOWN Alzheimer’s Disease Neuroimaging Initiative
Dec 19, 2015·Alzheimer's Research & Therapy·Katarzyna AdamczukRik Vandenberghe
Nov 13, 2015·Neurobiology of Aging·Betty M TijmsFrederik Barkhof
Apr 2, 2016·Current Behavioral Neuroscience Reports·Joey A ContrerasAndrew J Saykin
Jul 22, 2015·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Clifford R JackMichael Weiner
Jul 22, 2015·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Ju-Hee KangUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Mar 21, 2017·Annals of Neurology·Betty M TijmsPieter Jelle Visser
Oct 28, 2017·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Piotr LewczukUNKNOWN Members of the WFSBP Task Force Working on this Topic: Peter Riederer, Carla Gallo, Dimitrios Kapogiannis, Andrea Lopez Mato
Apr 18, 2018·Journal of Alzheimer's Disease : JAD·Pierre-François MeyerUNKNOWN PREVENT-AD Research Group
Aug 19, 2016·EMBO Molecular Medicine·Niklas MattssonUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Nov 11, 2017·Alzheimer's & Dementia : Translational Research & Clinical Interventions·Daniela BertensPieter Jelle Visser
Aug 3, 2019·Journal of Neurology, Neurosurgery, and Psychiatry·Sarah Teuber-HanselmannKathy Keyvani
Nov 3, 2016·Current Opinion in Neurology·Luka Kulic, Paul G Unschuld
Aug 2, 2019·Aging·Kai-Xin DouUNKNOWN Alzheimer’s Disease Neuroimaging Initiative (ADNI)
May 11, 2016·Neurology·Philip S InselUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Feb 15, 2017·Alzheimer's Research & Therapy·Daniela BertensPieter Jelle Visser
Sep 27, 2018·Annals of Clinical and Translational Neurology·Betty M TijmsUNKNOWN for ADNI
Feb 8, 2018·PloS One·Mony J de LeonUNKNOWN National Alzheimer’s Coordinating Center
Mar 27, 2020·Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring·Ivan KoychevSusan M Resnick
Mar 25, 2019·Alzheimer's Research & Therapy·Gemma SalvadóUNKNOWN Alzheimer’s Disease Neuroimaging Initiative, for the ALFA Study
Oct 25, 2017·Alzheimer's Research & Therapy·Ronald LautnerHenrik Zetterberg
Oct 7, 2020·Sleep Medicine Reviews·Claudio LiguoriBiancamaria Guarnieri
Feb 19, 2020·Biological Psychiatry·Jeremy A ElmanUNKNOWN Alzheimer’s Disease Neuroimaging Initiative
Feb 14, 2021·Journal of Alzheimer's Disease : JAD·Weina YaoUNKNOWN Alzheimer’s Disease Neuroimaging Initiative
Jun 8, 2021·Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring·Xue-Ning ShenUNKNOWN Alzheimer's Disease Neuroimaging Initiative

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.